Abstract
Background
Rotational atherectomy (RA) may cause bradyarrhythmias and transitory atrioventricular block when performed in the right coronary artery (RCA) or a dominant circumflex (CX) coronary artery. However, there are no studies of a solution that can prevent coronary flow deterioration and bradycardia complications that may occur during RA. We aimed to create an alternative rota-flush solution to minimize the risk of bradycardia and complete atrioventricular block (AVB) that can occur during RA.
Materials and methods
The study comprised 60 patients who were randomly divided into two groups: 30 received rotaphylline (= 240 mg aminophylline, 10,000 U unfractionated heparin, and 2000 mcg nitroglycerin to 1000 mL saline), and 30 received the traditional rota-flush (= 10,000 U unfractionated heparin, 2000 mcg nitroglycerin, and 1000 mL saline). The incidence of bradycardia or high-grade AVB (HAVB) during RA, coronary slow-flow phenomenon or no-reflow phenomenon, and coronary spasm were the primary endpoints of the study. Procedure success and RA-related procedural complications were secondary endpoints.
Results
The use of rotaphylline was an independent predictor of bradycardia and HAVB after accounting for all other factors (OR: 0.47, 95% CI: 0.24–0.79, p < 0.001). Lesion length (OR: 2.17, 95% CI: 1.24–3.04, p < 0.001), burr-to-artery ratio (OR: 0.59, 95% CI: 0.39–1.68, p < 0.001), and total run duration (OR: 0.79, 95% CI: 0.35–1.43, p < 0.001) were additional independent predictors.
Conclusion
Bradycardia and the development of HAVB may be avoided by rotaphylline intracoronary infusion during RA applied to the RCA and dominant CX lesions. Multicenter studies including sizable patient populations should be conducted to validate the present findings.
Zusammenfassung
Hintergrund
Eine Rotations-Atherektomie (RA) kann Bradyarrhythmien und einen transitorischen Atrioventrikularblock (AVB) verursachen, wenn sie in der A. coronaria dextra (RCA) oder in einem dominanten Ramus circumflexus (CX) durchgeführt wird. Es gibt jedoch keine Studien hinsichtlich einer Lösung, mit der die Verhinderung einer Flussverminderung in den Koronarien und bradykarder Komplikationen, die bei einer RA auftreten können, möglich wird. Ziel der Autoren war es, eine alternative Rota-Flush-Lösung zu entwickeln, um das Risiko einer Bradykardie und eines kompletten AVB, die während einer RA auftreten können, zu minimieren.
Material und Methoden
An der Studie nahmen 60 Patienten teil, die randomisiert in 2 Gruppen aufgeteilt wurden: So erhielten 30 Rotaphyllin (240 mg Aminophyllin, 10.000 U unfraktioniertes Heparin und 2000 μg Nitroglycerin auf 1000 ml Kochsalzlösung) und 30 die traditionelle Rota-Flush-Lösung (10.000 U unfraktioniertes Heparin, 2000 μg Nitroglycerin und 1000 ml Kochsalzlösung). Primäre Endpunkte der Studie waren die Inzidenz einer Bradykardie oder eines hochgradigen AVB (HAVB) während einer RA, ein koronares Slow-Flow-Phänomen oder No-Reflow-Phänomen sowie Koronarspasmen. Der Erfolg des Verfahrens und RA-bezogene Verfahrenskomplikationen waren sekundäre Endpunkte.
Ergebnisse
Die Verwendung von Rotaphyllin war ein unabhängiger Prädiktor einer Bradykardie und eines HAVB nach Berücksichtigung sämtlicher anderer Faktoren (Odds Ratio, OR: 0,47; 95 %-Konfidenzintervall, 95 %-KI: 0,24–0,79; p < 0,001). Die Länge der Läsion (OR 2,17; 95 %-KI: 1,24–3,04; p < 0,001), das Verhältnis zwischen Bohrer und Arterie (OR 0,59; 95 %-KI: 0,39–1,68; p < 0,001) und die Gesamtbetriebsdauer (OR 0,79; 95 %-KI: 0,35–1,43; p < 0,001) waren zusätzliche unabhängige Prädiktoren.
Schlussfolgerung
Eine Bradykardie und die Entwicklung eines HAVB können durch die intrakoronare Infusion von Rotaphyllin während der RA von Läsionen der RCA und eines dominanten CX verhindert werden. Multizenterstudien mit großen Patientenpopulationen sollten durchgeführt werden, um die vorliegenden Ergebnisse zu validieren.
Similar content being viewed by others
References
Bamford P, Collins N, Boyle A (2022) A state-of-the-art review: the percutaneous treatment of highly calcified lesions. Heart Lung Circ. https://doi.org/10.1016/j.hlc.2022.08.009
De Maria GL, Scarsini R, Banning AP (2019) Management of calcific coronary artery lesions: is it time to change our Interventional therapeutic approach? JACC Cardiovasc Interv 12(15):1465–1478. https://doi.org/10.1016/j.jcin.2019.03.038
Sakakura K, Ito Y, Shibata Y et al (2021) Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics. Cardiovasc Interv Ther 36(1):1–18. https://doi.org/10.1007/s12928-020-00715-w
Barbato E, Shlofmitz E, Milkas A, Shlofmitz R, Azzalini L, Colombo A (2017) State of the art: evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses—from debulking to plaque modification, a 40-year-long journey. EuroIntervention 13(6):696–705. https://doi.org/10.4244/EIJ-D-17-00473
Kusumoto H, Ishibuchi K, Hasegawa K, Otsuji S (2022) Trans-coronary pacing via Rota wire prevents bradycardia during rotational atherectomy: a case report. Eur Heart J Case Rep 6(2):ytac13. https://doi.org/10.1093/ehjcr/ytac013
Cha KS, Kim MH, Kim YD, Kim JW, Kim SJ, Kim JS (2003) The impact of preprocedural aminophylline administration on the development of bradyarrhythmias and hemodynamic changes during rotational atherectomy. Korean J Med 64:647–654
Megaly M, Sandoval Y, Lillyblad MP, Brilakis ES (2018) Aminophylline for preventing bradyarrhythmias during orbital or rotational Atherectomy of the right coronary artery. J Invasive Cardiol 30(5):186–189
Murad B (2008) Intracoronary aminophylline for management of bradyarrhythmias during thrombectomy with the AngioJet catheter. J Invasive Cardiol 20(8 Suppl A):12A–18A
Barbato E, Carrie D, Dardas P et al (2015) European expert consensus on rotational atherectomy. EuroIntervention 11:30–36. https://doi.org/10.4244/EIJV11I1A6
Chandra S, Choudhary R, Chaudhary G et al (2022) Evaluation of only heparin-based route-flush solution against alternative route-flush solution in patients with severe coronary artery calcification undergoing rotational atherectomy. Indian Heart J 74(1):22–27. https://doi.org/10.1016/j.ihj.2021.12.001
Whiteside HL, Ratanapo S, Sey A, Omar A, Kapoor D (2018) Efficacy of a heparin based route-flush solution in patients undergoing rotational atherectomy. Cardiovasc Revasc Med 19(3):333–e337
Matsuo H, Watanabe S, Watanabe T et al (2007) Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy—a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil. Am Heart J 154:e991–e996. https://doi.org/10.1016/j.ahj.2007.07.036
Cohen BM, Weber VJ, Blum RR (1996) Cocktail attenuation of rotational ablation flow effects (CARAFE) study: pilot. Cathet Cardiovasc Diagn. 1996;Suppl 3:69–72
Hanna GP, Yhip P, Fujise K, Schroth GW, Rosales OR, Anderson HV, Smalling RW (1999) Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon. Catheter Cardiovasc Interv 48(3):275–278
Lee MS, Kim M‑H, Rha S‑W (2016) Alternative route-flush solution for patients with severe coronary artery calcification who undergone rotational atherectomy. J Invasive Cardiol 29(1):25–28
Berne RM (1963) Cardiac nucleotides in hypoxia: possible role of coronary blood flow. Am J Physiol 204:317–322
Belardinelli L, Belloni FL, Rubio R, Berne RM (1980) Atrioventricular conduction disturbances during hypoxia. Possible role of adenosine in rabbit and guinea pig heart. Circ Res 47:684
Shah PK, Nalos P, Peter T (1987) Atropine resistant post infarction complete AV block: possible role of adenosine and improvement with aminophylline. Am Heart J 113:194
Gupta A, Jain A, Kala SC (1991) Role of aminophylline in atropine resistant atrioventricular block. J Assoc Physicians India 39:214
Abu-Laban RB, McIntyre CM, Christenson JM et al (2006) Aminophylline in bradyasystolic cardiac arrest: a randomised placebo-controlled trial. Lancet 367:1577
Patel AK, Skatrud JB, Thomsen JH (1981) Cardiac arrhythmias due to oral aminophylline in patients with chronic obstructive pulmonary disease. Chest 80:661
Varriale P, Ramaprasad S (1993) Aminophylline induced atrial fibrillation. Pacing Clin Electrophysiol 16:1953
Oei HH, Hale TH, Gandhi SS, Pilla TJ, Wegria R (1977) Effect of aminophylline on coronary circulation and cardiac metabolism. Arch Int Pharmacodyn Ther 229:95–104
Belardinelli L, Fenton RA, West A, Linden J, Althaus JS, Berne RM (1982) Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of Isolated perfused guinea pig and rat hearts. Circ Res 51:569
Knott JD, Sabbah MS, Lewis BR et al (2023) Prophylactic Intravenous Aminophylline for Preventing Bradyarrhythmias During Coronary Atherectomy: A 10-Year Single-Center Experience. J Soc Cardiovasc Angiogr Interv. https://doi.org/10.1016/j.jscai.2023.100590
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
E. Acar, S. Izci, I. Donmez, N. Ozgul, E. Ozcan, T. Kaygusuz, O. Kayabası, Y. Güneş, I.A. Izgi and C. Kirma declare that they have no competing interests.
For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.
Rights and permissions
About this article
Cite this article
Acar, E., Izci, S., Donmez, I. et al. A mix of aminophylline and heparin plus nitroglycerin can reduce bradycardia during rotational atherectomy on the right coronary artery and dominant circumflex artery. Herz 48, 480–486 (2023). https://doi.org/10.1007/s00059-023-05195-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-023-05195-1